Markets

Has Amgen (AMGN) Outpaced Other Medical Stocks This Year?

Investors focused on the Medical space have likely heard of Amgen (AMGN), but is the stock performing well in comparison to the rest of its sector peers? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

Amgen is one of 817 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. AMGN is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for AMGN's full-year earnings has moved 1.63% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.

According to our latest data, AMGN has moved about 8.04% on a year-to-date basis. In comparison, Medical companies have returned an average of 0.02%. This means that Amgen is outperforming the sector as a whole this year.

Looking more specifically, AMGN belongs to the Medical - Biomedical and Genetics industry, a group that includes 327 individual stocks and currently sits at #85 in the Zacks Industry Rank. This group has lost an average of 17.64% so far this year, so AMGN is performing better in this area.

Going forward, investors interested in Medical stocks should continue to pay close attention to AMGN as it looks to continue its solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Amgen Inc. (AMGN): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AMGN

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More